Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Sudarshan Pharma Industries Ltd Press Release May 21 2026

· Issued by Sudarshan Pharma Industries Ltd

We refer to the Corporate Announcement dated May 15, 2026, (Annexure A) setting out fixed conversion rate of Rs.95.93 per US Dollar for FCCB issue. RBI rate as on date of signing subscription agreement revised to Rs.96.8441 per US Dollar. We enclose the revised Annexure A reflecting the updated conversion terms.

View Attachment